Comparison of the toxicological potential of two JUUL ENDS products to reference cigarette 3R4F and filtered air in a 90-day nose-only inhalation toxicity study
Food and Chemical Toxicology · 2023
DOI: 10.1016/j.fct.2023.113917 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2023. Verfasst von Rahat Wadhwa Desai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Juul Labs, Inc, Washington DC, USA. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Tobacco Products. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Electronic nicotine delivery systems (ENDS) are generally recognized as less harmful alternatives for those who would otherwise continue to smoke cigarettes. The potential toxicity of aerosols generated from JUUL Device and Virginia Tobacco (VT3) or Menthol (ME3) JUULpods at 3.0% nicotine concentration was assessed in rats exposed at target aerosol concentrations of 1400 μg/L for up to 6 h/day on a 5 day/week basis for at least 90 days (general accordance with OECD 413). 3R4F reference cigarette smoke (250 μg/L) and Filtered Air were used as comparators. JUUL ENDS product aerosol exposures at >5x the 3R4F cigarette smoke level resulted in greater plasma nicotine and cotinine levels (up to 2x). Notable cigarette smoke related effects included pronounced body weight reductions in male rats, pulmonary inflammation evidenced by elevated lactate dehydrogenase, pro-inflammatory cytokines and neutrophils in bronchoalveolar lavage fluid, increased heart and lung weights, and minimal to marked respiratory tract histopathology. In contrast, ENDS aerosol exposed animals had minimal body weight changes, no measurable inflammatory changes and minimal to mild laryngeal squamous metaplasia. Despite the higher exposure levels, VT3 and ME3 did not result in significant toxicity or appreciable respiratory histopathology relative to 3R4F cigarette smoke following 90 days administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Juul Labs, Inc, Washington DC, USA.
- Protatonce Ltd, National Centre of Scientific Research Demokritos, Patriarchou Grigoriou E' & Neapoleos 27, Technological Park Lefkippos, Bldg 27, 15341, Ag. Paraskevi, Attiki, Greece.
- AmplifyBio, 1425 NE Plain City-Georgesville Rd, West Jefferson, OH, 43162, USA.
- Kozmin Consulting LLC, Flat Rock, NC, 28731, USA.
- Juul Labs, Inc, Washington DC, USA. Electronic address: Guy.Lalonde@JUUL.com.
Zitieren
APA
Desai, R. W., Demir, K., Tsolakos, N., Moir-Savitz, T. R., Gaworski, C. L., Weil, R., Oldham, M. J., & Lalonde, G. (2023). Comparison of the toxicological potential of two JUUL ENDS products to reference cigarette 3R4F and filtered air in a 90-day nose-only inhalation toxicity study. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2023.113917
Vancouver
Desai RW, Demir K, Tsolakos N, Moir-Savitz TR, Gaworski CL, Weil R, et al. Comparison of the toxicological potential of two JUUL ENDS products to reference cigarette 3R4F and filtered air in a 90-day nose-only inhalation toxicity study. Food and Chemical Toxicology. 2023. doi:10.1016/j.fct.2023.113917
BibTeX
@article{Desai2023,
author = {Desai, Rahat Wadhwa and Demir, Kubilay and Tsolakos, Nikos and Moir-Savitz, Tessa R and Gaworski, Charles L and Weil, Roxana and Oldham, Michael J and Lalonde, Guy},
title = {Comparison of the toxicological potential of two JUUL ENDS products to reference cigarette 3R4F and filtered air in a 90-day nose-only inhalation toxicity study},
journal = {Food and Chemical Toxicology},
year = {2023},
doi = {10.1016/j.fct.2023.113917}
}
EUVIMED